Typhoid fever: Current concepts

Infectious Diseases in Clinical Practice

Volumn 14, Issue 5, 2006, Pages 266-272

  Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; OFLOXACIN; PARACETAMOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TYPHOID VACCINE; WATER;

ABDOMINAL BLEEDING; ABDOMINAL TENDERNESS; AFRICA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTEREMIA; BLOOD ANALYSIS; BONE MARROW NECROSIS; BRADYCARDIA; CARDIOGENIC SHOCK; CASE MANAGEMENT; CEREBELLAR ATAXIA; CHOLECYSTITIS; CHOREA; CLINICAL FEATURE; COMMUNITY; DELIRIUM; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DISSEMINATED INTRAVASCULAR CLOTTING; ELECTROLYTE BALANCE; ENDEMIC DISEASE; ENDOCARDITIS; EPIDEMIC; FOOD; GASTROINTESTINAL HEMORRHAGE; GUILLAIN BARRE SYNDROME; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HEART SINOATRIAL BLOCK; HEMOLYTIC UREMIC SYNDROME; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYDRATION; HYGIENE; HYPOTENSION; INCIDENCE; INTESTINE PERFORATION; INTRACRANIAL HYPERTENSION; JAUNDICE; LABORATORY DIAGNOSIS; LIVER DYSFUNCTION; LYMPHADENITIS; MENINGITIS; MORBIDITY; MYOCARDITIS; NEPHROTIC SYNDROME; NEUROLOGICAL COMPLICATION; ORCHITIS; PAROTITIS; PERITONITIS; POLYMERASE CHAIN REACTION; PSYCHOSIS; PYELONEPHRITIS; REST; REVIEW; SALMONELLA TYPHI; SALMONELLOSIS; SANITATION; SEROLOGY; SOUTH ASIA; STUDY; TYPHOID FEVER; URBAN POPULATION; VACCINATION; VOMITING;

EID: 33748808439     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000222625.11629.f4     Document Type: Review

References (53)

1. Glynn JR, Hornick RB, Levine MM, et al. Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used. Epidemiol Infect. 1995;115:23-30.
2. Dunstan SJ, Stephens HA, Blackwell JM, et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis. 2001;183:261-268.
3. Graham SM. Salmonellosis in children in developing and developed countries and populations. Curr Opin Infect Dis. 2002;15:507-512.
4. Bhan MK, Bahl R, Sazawal S, et al. Association between Helicobacter pylori infection and increased risk of typhoid fever. J Infect Dis. 2002;186:1857-1860.
5. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ. 1994;72:957-971.
6. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346-353.
7. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet. 1999;354:734-737.
8. Brooks WA, Hossain A, Goswami D, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis. 2005;11:326-329.
9. Siddiqui F, Rabbani F, Haider R, et al. Typhoid fever in children: some epidemiological considerations. Int J Infect Dis. 2006 January [epublication ahead of printing].
10. Ferreccio C, Levine MM, Manterola A, et al. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr. 1984;104:899-901.
11. Topley JM. Mild typhoid fever. Arch Dis Child. 1986;61:164-167.
12. Ochiai RL, Wang X, von Seidlein L, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis. 2005;11:1764-1766.
13. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
14. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997;24(suppl 1):S106-S109.
15. Renuka K, Sood S, Das BK, et al. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol. 2005;54:999-1000.
16. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481-493.
17. Bhutta ZA, Naqvi SH, Razzaq RA, et al. Multiple drug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis. 1991;13:832-836.
18. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child. 1996;75:214-217.
19. Hathout S el-D. Relation of schistosomiasis to typhoid fever. J Egypt Public Health Assoc. 1970;45:145-156.
20. Nsutebu EF, Martins P, Adiogo D. Prevalence of typhoid fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon. Trop Med Int Health. 2003;8:575-578.
21. Biswal N, Mathai B, Bhatia BD, et al. Enteric fever: a changing perspective. Indian Pediatr. 1994;31:813-819.
22. Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol. 1998;36:1683-1687.
23. Chandel DS, Chaudhry R, Dhawan B, et al. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis. 2000;6:420-421.
24. van Basten JP, Stockenbrugger R. Typhoid perforation. A review of the literature since 1960. Trop Geogr Med. 1994;46:336-339.
25. Johnson AO, Aderele WI. Enteric fever in childhood. J Trop Med Hyg. 1981;84:29-35.
26. Levine MM, Black RE, Lanata C. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis. 1982;146:724-726.
27. Prakash P, Mishra OP, Singh AK, et al. Evaluation of nested PCR in diagnosis of typhoid fever. J Clin Microbiol. 2005;43:431-432.
28. Khuri-Bulos N. Enteric fevers in children. The importance of age in the varying clinical picture. Clin Pediatr (Phila). 1981;20:448-452.
29. Bhutta ZA, Mansurali N. Rapid serologic diagnosis of pediatric typhoid fever in an endemic area: a prospective comparative evaluation of two dot-enzyme immunoassays and the Widal test. Am J Trop Med Hyg. 1999;61:654-657.
30. Olsen SJ, Pruckler J, Bibb W, et al. Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol. 2004;42:1885-1889.
31. Watt G, Jongsakul K, Ruangvirayuth R, et al. Short report: prospective evaluation of a multi-test strip for the diagnoses of scrub and murine typhus, leptospirosis, dengue fever, and Salmonella typhi infection. Am J Trop Med Hyg. 2005;72:10-12.
32. Bhutta ZA, Khan I, Molla AM. Therapy of multidrug-resistant typhoidal salmonellosis in childhood: a randomized controlled comparison of therapy with oral cefixime versus IV ceftriaxone. Pediatr Infect Dis J. 1994;13:990-994.
33. van den Bergh ET, Gasem MH, Keuter M, et al. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop Med Int Health. 1999;4:211-215.
34. World Health Organization. Treatment of typhoid fever In: Background document: the diagnosis, prevention, and treatment of typhoid fever. Geneva, Switzerland: Department of Communicable Disease Surveillance and Response and Department of Vaccines and Biologicals, World Health Organization; 2003;19-23. Available at: www.who.int/entity/vaccine_research/documents/en/ typhoid_diagnosis.pdf. Accessed June 20, 2006.
35. Vinh H, Duong NM, Phuong le T, et al. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Ann Trop Paediatr. 2005;25:17-22.
36. Frenck RW Jr, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis. 2004;38:951-957.
37. Thomas MG, Woodhouse AF, Shore KP, et al. Short-course ciprofloxacin treatment for enteric fever: caveat emptor! Intern Med J. 2003;33:472-473.
38. Bhutta ZA, Khan IA, Shadmani M. Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan. Antimicrob Agents Chemother. 2000;44:450-452.
39. Zaidi AK, Hasan R, Bhutta ZA. Typhoid fever. N Engl J Med. 2003;348:1182-1184.
40. Thaver D, Zaidi AK, Critchley J, et al. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2005;(2):CD004530.
41. Punjabi NH, Hoffman SL, Edman DC, et al. Treatment of severe typhoid fever in children with high-dose dexamethasone. Pediatr Infect Dis J. 1988;7:598-600.
42. Hosoglu S, Celen MK, Geyik MF, et al. Risk factors for typhoid fever among adult patients in Diyarbakir, Turkey. Epidemiol Infect. 2006;134:612-616.
43. Tran HH, Bjune G, Nguyen BM, et al. Risk factors associated with typhoid fever in Son La province, northern Vietnam. Trans R Soc Trop Med Hyg. 2005;99:819-826.
44. Aye TT, Siriarayapon P. Typhoid fever outbreak in Madaya township, Mandalay division, Myanmar, September 2000. J Med Assoc Thai. 2004;87:395-399.
45. Vollaard AM, Ali S, van Asten HA, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA. 2004;291:2607-2615.
46. Gasem MH, Dolmans WM, Keuter MM, et al. Poor food hygiene and housing as risk factors for typhoid fever in Semarang, Indonesia. Trop Med Int Health. 2001;6:484-490.
47. Luxemburger C, Chau MC, Mai NL, et al. Risk factors for typhoid fever in the Mekong delta, southern Viet Nam: a case-control study. Trans R Soc Trop Med Hyg. 2001;95:19-23.
48. Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis. 1999;179:1416-1422.
49. Luby SP, Faizan MK, Fisher-Hoch SP, et al. Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiol Infect. 1998;120:129-138.
50. Velema JP, van Wijnen G, Bult P, et al. Typhoid fever in Ujung Pandang, Indonesia - high-risk groups and high-risk behaviours. Trop Med Int Health. 1997;2:1088-1094.
51. Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis. 2003;3:275-281.
52. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005;366:225-233.
53. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med. 2001;344:1263-1269.